Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Category
Buffers and Solutions
CLIA Kit
Cytokines and Chemokines
Diagnostic Test Kits
ELISA Kit
Enzyme Products
Flow Cytometry Reagents
Peptide
Recombinant Protein
Secondary Antibodies
Western Blot Reagents
cDNA Clone
siRNA
Showing 50 of 81 products
ImageCatalog NumberProduct NameSizePriceAdd to Cart
Breast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 100 cases/ 100 cores, replacing BR1002aBR1002bBreast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 100 cases/ 100 cores, replacing BR1002a
1 Each
Sign In for Pricing
Breast cancer with ER Immunohistochemistry control tissue array, including pathology grade, TNM, clinical stage and IHC results of ER/PR/Her-2/Ki67, 10 cases/10 cores, replacing PM2-ERPM2a-ERBreast cancer with ER Immunohistochemistry control tissue array, including pathology grade, TNM, clinical stage and IHC results of ER/PR/Her-2/Ki67, 10 cases/10 cores, replacing PM2-ER
1 Each
Sign In for Pricing
Ovary cancer tissue array with adjacent normal tissue as control, including TNM and pathology grade, 70 cases/70 cores, replacing OV702aOV702bOvary cancer tissue array with adjacent normal tissue as control, including TNM and pathology grade, 70 cases/70 cores, replacing OV702a
1 Each
Sign In for Pricing
Kidney cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 coresKD1503Kidney cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores
1 Each
Sign In for Pricing
Kidney cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/96 coresKD962Kidney cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/96 cores
1 Each
Sign In for Pricing
Multiple cervix cancer tissue array with 4 normal tissues control from autopsy, 24 cases/48 cores, with grade and stage dataCR482Multiple cervix cancer tissue array with 4 normal tissues control from autopsy, 24 cases/48 cores, with grade and stage data
1 Each
Sign In for Pricing
Esophageal cancer tissue array with esophagus tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing ES482-ES482aES482aEsophageal cancer tissue array with esophagus tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing ES482-ES482a
each
Sign In for Pricing
Lung squamous cell cancer tissue array with matched cancer adjacent tissue as control, including pathology grade, TNM/Stage (AJCC 8th edition), 50 cases/150 cores (core size 1.5mm), replacing LC1505LC1505aLung squamous cell cancer tissue array with matched cancer adjacent tissue as control, including pathology grade, TNM/Stage (AJCC 8th edition), 50 cases/150 cores (core size 1.5mm), replacing LC1505
1 Each
Sign In for Pricing
Stomach cancer tissue array with normal tissue as control, including TNM，stage and pathology grade，80 cases/80 coresST809Stomach cancer tissue array with normal tissue as control, including TNM，stage and pathology grade，80 cases/80 cores
1 Each
Sign In for Pricing
Liver cancer tissue array with normal liver tissue as control, including pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/ 24 cores, replacing T033aT033bLiver cancer tissue array with normal liver tissue as control, including pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/ 24 cores, replacing T033a
1 Each
Sign In for Pricing
Lung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, cases/ cores, replacing LC807aLC807bLung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, cases/ cores, replacing LC807a
1 Each
Sign In for Pricing
Endometrium cancer, endometrium hyperplasia tissue array with adjacent tissue as control, including pathology grade, TNM and clinical stage, 24 cases/24 coresFUR240Endometrium cancer, endometrium hyperplasia tissue array with adjacent tissue as control, including pathology grade, TNM and clinical stage, 24 cases/24 cores
24 Cases / 24 Cores
Sign In for Pricing
MCM3, Control Peptide, Human (Cervical Cancer Proto-oncogene 5, DNA Polymerase alpha Holoenzyme Associated Protein P1, DNA Replication Licensing Factor MCM3, HCC5, hRlf beta Subunit, Human Cervical Cancer Proto-oncogene 5, MGC1157, Minichromosome Maintenance Deficient 3, Minichromosome Maintenance Protein 3, P1-h, P1.h, P1-MCM3, P1-Protein, P102 Protein, Replication Licensing Factor beta Subunit, RLF beta Subunit, RLF Subunit beta, RLFB) discontinuedM2749-31H1MCM3, Control Peptide, Human (Cervical Cancer Proto-oncogene 5, DNA Polymerase alpha Holoenzyme Associated Protein P1, DNA Replication Licensing Factor MCM3, HCC5, hRlf beta Subunit, Human Cervical Cancer Proto-oncogene 5, MGC1157, Minichromosome Maintenance Deficient 3, Minichromosome Maintenance Protein 3, P1-h, P1.h, P1-MCM3, P1-Protein, P102 Protein, Replication Licensing Factor beta Subunit, RLF beta Subunit, RLF Subunit beta, RLFB) discontinued
50 µg
Sign In for Pricing
BCAR3, Control Peptide (Breast Cancer Anti-estrogen Resistance Protein 3, Novel SH2-containing Protein 2, SH2 Domain-containing Protein 3B, NSP2, SH2D3B, UNQ271/PRO308)147705BCAR3, Control Peptide (Breast Cancer Anti-estrogen Resistance Protein 3, Novel SH2-containing Protein 2, SH2 Domain-containing Protein 3B, NSP2, SH2D3B, UNQ271/PRO308)
100 µg
Sign In for Pricing
BRDT, Control Peptide (Bromodomain Testis-specific Protein, RING3-like Protein, Cancer/Testis Antigen 9, CT9)147719BRDT, Control Peptide (Bromodomain Testis-specific Protein, RING3-like Protein, Cancer/Testis Antigen 9, CT9)
100 µg
Sign In for Pricing
LDHC, Control Peptide (L-lactate Dehydrogenase C Chain, LDH-C, Cancer/Testis Antigen 32, CT32, LDH Testis Subunit, LDH-X, LDH3, LDHX, MGC111073)148131LDHC, Control Peptide (L-lactate Dehydrogenase C Chain, LDH-C, Cancer/Testis Antigen 32, CT32, LDH Testis Subunit, LDH-X, LDH3, LDHX, MGC111073)
100 µg
Sign In for Pricing
TPTE, Control Peptide (Transmembrane Phosphatase with Tensin Homology, Cancer/Testis Antigen 44, CT44, PTEN2, Putative Tyrosine Protein Phosphatase, Tumor Antigen BJ-HCC-5)148615TPTE, Control Peptide (Transmembrane Phosphatase with Tensin Homology, Cancer/Testis Antigen 44, CT44, PTEN2, Putative Tyrosine Protein Phosphatase, Tumor Antigen BJ-HCC-5)
100 µg
Sign In for Pricing
XAGE1, Control Peptide (G Antigen Family D Member 2, Cancer/Testis Antigen 12.1, CT12.1, Protein XAGE-1, XAGE1A, GAGED2, XAGE1B, XAGE1C, XAGE1D, XAGE1E)148688XAGE1, Control Peptide (G Antigen Family D Member 2, Cancer/Testis Antigen 12.1, CT12.1, Protein XAGE-1, XAGE1A, GAGED2, XAGE1B, XAGE1C, XAGE1D, XAGE1E)
100 µg
Sign In for Pricing
ANO1, Control Peptide (Anoctamin-1, Discovered on Gastrointestinal Stromal Tumors Protein 1, Oral Cancer Overexpressed Protein 2, Transmembrane Protein 16A, Tumor-amplified and Overexpressed Sequence 2, DOG1, ORAOV2, TAOS2, TMEM16A, FLJ10261)149304ANO1, Control Peptide (Anoctamin-1, Discovered on Gastrointestinal Stromal Tumors Protein 1, Oral Cancer Overexpressed Protein 2, Transmembrane Protein 16A, Tumor-amplified and Overexpressed Sequence 2, DOG1, ORAOV2, TAOS2, TMEM16A, FLJ10261)
50 µg
Sign In for Pricing
PTPRH, Control Peptide (Receptor-type Tyrosine-protein Phosphatase H, R-PTP-H, Stomach Cancer-associated Protein Tyrosine Phosphatase 1, SAP-1, Transmembrane-type Protein-tyrosine Phosphatase Type H, SAP1, FLJ39938, MGC133058, MGC133059)148781PTPRH, Control Peptide (Receptor-type Tyrosine-protein Phosphatase H, R-PTP-H, Stomach Cancer-associated Protein Tyrosine Phosphatase 1, SAP-1, Transmembrane-type Protein-tyrosine Phosphatase Type H, SAP1, FLJ39938, MGC133058, MGC133059)
100 µg
Sign In for Pricing
CRISP2, Control Peptide (Cysteine-rich Secretory Protein 2, CRISP-2, Cancer/Testis Antigen 36, CT36, Testis-specific Protein TPX-1, GAPDL5, TPX1)149479CRISP2, Control Peptide (Cysteine-rich Secretory Protein 2, CRISP-2, Cancer/Testis Antigen 36, CT36, Testis-specific Protein TPX-1, GAPDL5, TPX1)
50 µg
Sign In for Pricing
Brain cancer and brain tissue array as control, including pathology grade, 100 cases/100 cores, replacing GL1001aGL1001bBrain cancer and brain tissue array as control, including pathology grade, 100 cases/100 cores, replacing GL1001a
100 Cases / 100 Cores
Sign In for Pricing
PR Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer, 11 cases/11 coresPM2-PRPR Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer, 11 cases/11 cores
1 Each
Sign In for Pricing
Colon cancer tissue array with matched adjacent tissue as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 coresCO1504Colon cancer tissue array with matched adjacent tissue as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores
1 Each
Sign In for Pricing
Lung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 102 cases/102 cores-LC1021LC1021Lung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 102 cases/102 cores-LC1021
each
Sign In for Pricing
Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with TNM data-CR483CR483Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with TNM data-CR483
each
Sign In for Pricing
Esophagus cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 102 cases/ 102 cores-ES1021ES1021Esophagus cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 102 cases/ 102 cores-ES1021
each
Sign In for Pricing
Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases/80 cores, with grade informationMC802Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases/80 cores, with grade information
1 Each
Sign In for Pricing
Stomach cancer tissue array with normal tissue as controlST1021Stomach cancer tissue array with normal tissue as control
each
Sign In for Pricing
Breast cancer tissue array containing triple negative (TNBC) cases, including pathology grade, TNM, clinical stage and IHC results of ER, PR and Her-2 (6 cases of positive control), 120 cases/120 cores-BRE1201BRE1201Breast cancer tissue array containing triple negative (TNBC) cases, including pathology grade, TNM, clinical stage and IHC results of ER, PR and Her-2 (6 cases of positive control), 120 cases/120 cores-BRE1201
each
Sign In for Pricing
Multiple organ cancer tissue array with matched non-metastatic lymph node tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 96 cores. The design and the corresponding MET961aNMET961Multiple organ cancer tissue array with matched non-metastatic lymph node tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 96 cores. The design and the corresponding MET961a
1 Each
Sign In for Pricing
Multiple pancreatic cancer with 4 normal tissues control from autopsy, 24 cases/48 cores, with grade and stage-PA481PA481Multiple pancreatic cancer with 4 normal tissues control from autopsy, 24 cases/48 cores, with grade and stage-PA481
each
Sign In for Pricing
Pancreatic cancer tissue array, with cancer adjaceent tissue and normal tissue as control, including duct adenocarcinoma ( PADC), cancer adjaceent pancreatic and normal tissue TNM, clinical stage and pathology grade, 80 cases/ 80 cores ( 1.5mm)-PA807PA807Pancreatic cancer tissue array, with cancer adjaceent tissue and normal tissue as control, including duct adenocarcinoma ( PADC), cancer adjaceent pancreatic and normal tissue TNM, clinical stage and pathology grade, 80 cases/ 80 cores ( 1.5mm)-PA807
each
Sign In for Pricing
Colon cancer, colonic disease and normal colon control tissue array, including pathology grade, with MMR (MLH1/PMS2/MSH2/MSH6) IHC results, TNM and clinical stage (AJCC 8th edition), 102 cases/102 cores （cores size 1.5mm）, replacing CO1021aCO1021cColon cancer, colonic disease and normal colon control tissue array, including pathology grade, with MMR (MLH1/PMS2/MSH2/MSH6) IHC results, TNM and clinical stage (AJCC 8th edition), 102 cases/102 cores （cores size 1.5mm）, replacing CO1021a
1 Each
Sign In for Pricing
N33 (TUSC3, tumor suppressor candidate 3, D8S1992, MGC13453, N33, OST3A, Putative prostate cancer tumor suppressor) (Control Peptide) discontinuedN5379-06-PN33 (TUSC3, tumor suppressor candidate 3, D8S1992, MGC13453, N33, OST3A, Putative prostate cancer tumor suppressor) (Control Peptide) discontinued
100 µg
Sign In for Pricing
EBAG9, Control Peptide (Estrogen Receptor-binding Fragment-associated Gene 9 Protein, EB9, Cancer-associated Surface Antigen RCAS1, PDAF, Receptor-binding Cancer Antigen Expressed on SiSo Cells, RCAS1)147875EBAG9, Control Peptide (Estrogen Receptor-binding Fragment-associated Gene 9 Protein, EB9, Cancer-associated Surface Antigen RCAS1, PDAF, Receptor-binding Cancer Antigen Expressed on SiSo Cells, RCAS1)
100 µg
Sign In for Pricing
LDHC, Control Peptide (L-lactate Dehydrogenase C Chain, LDH-C, Cancer/Testis Antigen 32, CT32, LDH Testis Subunit, LDH-X, LDH3, LDHX, MGC111073)148130LDHC, Control Peptide (L-lactate Dehydrogenase C Chain, LDH-C, Cancer/Testis Antigen 32, CT32, LDH Testis Subunit, LDH-X, LDH3, LDHX, MGC111073)
100 µg
Sign In for Pricing
MIC1, Control Peptide (Uncharacterized Protein C18orf8, Colon Cancer-associated Protein Mic1, Mic-1, C18orf8, FLJ23453)148183MIC1, Control Peptide (Uncharacterized Protein C18orf8, Colon Cancer-associated Protein Mic1, Mic-1, C18orf8, FLJ23453)
100 µg
Sign In for Pricing
MUC13, Control Peptide (Mucin-13, MUC-13, Down-regulated in Colon Cancer 1, DRCC1, RECC, UNQ6194/PRO20221, FLJ20063)148198MUC13, Control Peptide (Mucin-13, MUC-13, Down-regulated in Colon Cancer 1, DRCC1, RECC, UNQ6194/PRO20221, FLJ20063)
100 µg
Sign In for Pricing
SEPT1, Control Peptide (Septin-1, LARP, Peanut-like Protein 3, Serologically Defined Breast Cancer Antigen NY-BR-24, DIFF6, PNUTL3, MGC20394)148480SEPT1, Control Peptide (Septin-1, LARP, Peanut-like Protein 3, Serologically Defined Breast Cancer Antigen NY-BR-24, DIFF6, PNUTL3, MGC20394)
100 µg
Sign In for Pricing
XAGE1, Control Peptide (G Antigen Family D Member 2, Cancer/Testis Antigen 12.1, CT12.1, Protein XAGE-1, XAGE1A, GAGED2, XAGE1B, XAGE1C, XAGE1D, XAGE1E) discontinued148687XAGE1, Control Peptide (G Antigen Family D Member 2, Cancer/Testis Antigen 12.1, CT12.1, Protein XAGE-1, XAGE1A, GAGED2, XAGE1B, XAGE1C, XAGE1D, XAGE1E) discontinued
100 µg
Sign In for Pricing
CEP290, Control Peptide (Centrosomal Protein of 290kD, Cep290, Bardet-Biedl Syndrome 14 Protein, Cancer/Testis Antigen 87, CT87, Nephrocystin-6, Tumor Antigen se2-2, BBS14, KIAA0373, NPHP6, FLJ13615, FLJ21979, JBTS5, JBTS6, 3H11Ag)148719CEP290, Control Peptide (Centrosomal Protein of 290kD, Cep290, Bardet-Biedl Syndrome 14 Protein, Cancer/Testis Antigen 87, CT87, Nephrocystin-6, Tumor Antigen se2-2, BBS14, KIAA0373, NPHP6, FLJ13615, FLJ21979, JBTS5, JBTS6, 3H11Ag)
100 µg
Sign In for Pricing
MACC1, Control Peptide (Metastasis-associated in Colon Cancer Protein 1, SH3 Domain-containing Protein 7a5)149231MACC1, Control Peptide (Metastasis-associated in Colon Cancer Protein 1, SH3 Domain-containing Protein 7a5)
50 µg
Sign In for Pricing
BCAS1, Control Peptide (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1)149384BCAS1, Control Peptide (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1)
50 µg
Sign In for Pricing
WDR40A, Control Peptide (DCAF12, KIAA1892, TCC52, WDR40A, DDB1-and CUL4-associated Factor 12, Centrosome-related Protein TCC52, Testis Cancer Centrosome-related Protein, WD Repeat-containing Protein 40A)149417WDR40A, Control Peptide (DCAF12, KIAA1892, TCC52, WDR40A, DDB1-and CUL4-associated Factor 12, Centrosome-related Protein TCC52, Testis Cancer Centrosome-related Protein, WD Repeat-containing Protein 40A)
50 µg
Sign In for Pricing
Zebra fish breast and ovarian cancer susceptibility protein 2 (BRCA2) Control/blocking peptideAB-23028-PZebra fish breast and ovarian cancer susceptibility protein 2 (BRCA2) Control/blocking peptide
100 µg
Sign In for Pricing
Multiple Kidney cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with stage and grade dataKD483Multiple Kidney cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with stage and grade data
1 Each
Sign In for Pricing
Multiple skin cancer tissue array with 4 normal tissue control from autopsy, 24 cases/48 coresSK482Multiple skin cancer tissue array with 4 normal tissue control from autopsy, 24 cases/48 cores
1 Each
Sign In for Pricing
Skin basal cell cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores-SK484SK484Skin basal cell cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores-SK484
each
Sign In for Pricing
Normal colon tissue array with colon cancer tissue as control, including TNM, clinical stage and pathology grade, 24 cases/ 72 coresCO727Normal colon tissue array with colon cancer tissue as control, including TNM, clinical stage and pathology grade, 24 cases/ 72 cores
1 Each
Sign In for Pricing
1 2